Consistent with this regulatory relationship, a study in colorectal cancer indicated that macrophage-derived SHP-2 can inhibit TEK protein phosphorylation, thereby inactivating the PI3K/AKT/mTOR pathway and suppressing metastasis (Wu et al., 2023). This evidence concerns the gene AKT1 and colorectal cancer.